About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

W-SUDs for COVID-19 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 1NCT04460027

W-SUDs for COVID-19

The purpose of this study is to test the efficacy of a substance use disorder intervention delivered via a mobile application in an adult population during the COVID-19 pandemic. This study that will...

Lead sponsor: Woebot Health•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Woebot Health

Collaborators

Stanford University
National Institute on Drug Abuse (NIDA)

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•All genders aged 18-65 years
•Access to a smartphone
•Available and committed to engage with app and complete assessments
•Be willing to provide email address (as this is how assessment incentives will be distributed),
•Literate in English (as W-SUDs conversational and video materials will be in English).

Exclusion Criteria

•Pregnancy (as W-SUDs will not be specifically developed to address the unique needs of this population)
•History of severe drug/alcohol use
•History of opioid misuse without medication-assisted treatment
•Suicide attempt within the past year
•Opioid overdose within the past year

Related studies

An Effectiveness Trial of the PrEP for WINGS Study

NCT06853314 · HIV Infections, Alcohol Use Disorder, and more

RECRUITINGPhase 2/3

Alcohol Use Disorder and Cannabidiol

NCT05613608 · Alcohol Use Disorder

RECRUITINGPhase 1

Spironolactone in Alcohol Use Disorder (SAUD)

NCT05807139 · Alcohol Use Disorder

Efficacy of an EMDR App for PTSD and SUD

NCT07146633 · Posttraumatic Stress Disorder (PTSD), Substance Use Disorders

RECRUITINGPhase 1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

NCT07223983 · Alcohol Use Disorder, Weight Loss, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 21, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment180

Start dateJun 2020

Last updatedDec 21, 2022

Condition

Substance Use Disorders Alcohol Use Disorder

Locations shown

Stanford University

Palo Alto, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 21, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions